Cargando…
Cisplatin-Associated Ototoxicity: A Review for the Health Professional
Cisplatin is an effective drug used in the treatment of many cancers, yet its ototoxic potential places cancer patients, exposed to this drug, at risk of hearing loss, thus negatively impacting further on a patient's quality of life. It is paramount for health care practitioners managing such p...
Autores principales: | Paken, Jessica, Govender, Cyril D., Pillay, Mershen, Sewram, Vikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223030/ https://www.ncbi.nlm.nih.gov/pubmed/28115933 http://dx.doi.org/10.1155/2016/1809394 |
Ejemplares similares
-
Perspectives and practices of ototoxicity monitoring
por: Paken, Jessica, et al.
Publicado: (2020) -
Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa
por: Paken, Jessica, et al.
Publicado: (2023) -
Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity
por: Paken, Jessica, et al.
Publicado: (2021) -
Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting
por: Paken, Jessica, et al.
Publicado: (2022) -
Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa
por: Paken, Jessica, et al.
Publicado: (2021)